Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 64   

Articles published

NIPT 23.25 -0.25 (-1.06%)
price chart
Panmure Gordon Reiterates Buy Rating for Premaitha Health PLC (NIPT)
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “buy” rating reissued by equities researchers at Panmure Gordon in a research report issued on Friday.
Panmure Gordon Reiterates "Buy" Rating for Premaitha Health PLC (NIPT)  WKRB News
Premaitha Health PLC Given "Buy" Rating at Panmure Gordon (NIPT)  Mideast Time
Panmure Gordon Reconfirms GBX 31.00 Price Target On Premaitha Health Plc ...
Research professionals at Panmure Gordon have GBX 31.00 PT on Premaitha Health Plc (LON:NIPT). Panmure Gordon's PT would indicate a potential upside of 21.57% from the company's close price.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company, But Struggles To Sell Energy Unit  London South East
Related articles »  
PEG Ratio (5 yr expected):
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
Premaitha Health PLC (Formerly ViaLogy PLC) ("Premaitha" or the "Company ...
Premaitha Health PLC (Formerly ViaLogy PLC) ("Premaitha" or the "Company"): First Day of Dealings on AIM.
Related articles »  
Illumina Files Patent Infringement Suit in the United Kingdom Against ...
SAN DIEGO, Mar 16, 2015 (BUSINESS WIRE) -- Illumina, Inc. ILMN, -0.43% today announced that it and its wholly-owned subsidiary, Verinata Health Inc., (together “Illumina”) have filed a patent infringement suit against Premaitha Health plc in the High ...
Premaitha Health PLC Earns "Buy" Rating from Panmure Gordon (NIPT)
Premaitha Health PLC logo Panmure Gordon reissued their buy rating on shares of Premaitha Health PLC (LON:NIPT) in a research report released on Tuesday morning.
SMALL CAP IDEAS: Premaitha Health builds foundations for successful ...
Very often investors are asked to commit to the long haul when they buy into the latest new thing in the healthcare sector. With Premaitha Health the serious commercial groundwork is already underway as the diagnostics firm is ready to go to market ...
Premaitha Health To Post In Line Or Wider Operating Loss In Full Year
LONDON (Alliance News) - Premaitha Health PLC said Friday that it expects to post an operating loss of between GBP4.9 million to GBP5.3 million for the year to end-March, before accounting for costs associated to its reverse takeover and readmission to ...
Premaitha Health PLC's Buy Rating Reiterated at Panmure Gordon (NIPT)
Premaitha Health PLC (LON:NIPT) opened at 25.00 on Friday. Premaitha Health PLC has a one year low of GBX 10.00 and a one year high of GBX 34.00.